Alexandra Aponte Velez
Endocrinology, Diabetes & Metabolism · San Juan, PRNPI 1326491747
Payments from drug & device makers
Across 221 payments — averaging $27.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$748
- Dexcom, Inc.$503
- Novo Nordisk$498
- Amgen$485
- AstraZeneca$469
- Eli Lilly Export S.A. Puerto Rico Branch$438
- plus $3K from 19 others
What the payments were for
- Travel & lodging$581%
- Food & beverage$5,83497%
- Education$1162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 21 | $748 |
| Dexcom, Inc. | 21 | $503 |
| Novo Nordisk | 19 | $498 |
| Amgen(2 entities) | 14 | $485 |
| AstraZeneca | 18 | $469 |
| Eli Lilly Export S.A. Puerto Rico Branch | 20 | $438 |
| Abbott | 19 | $402 |
| Sanofi-aventis U.S. LLC | 13 | $355 |
| Medtronic | 5 | $292 |
| AbbVie | 13 | $268 |
| PBG Puerto Rico LLC | 12 | $248 |
| Novartis | 10 | $237 |
| Bayer Puerto Rico Inc. | 9 | $182 |
| Bayer | 3 | $157 |
| Radius Health, Inc. | 5 | $132 |
| Lilly USA, LLC | 1 | $119 |
| Johnson & Johnson | 4 | $109 |
| Corcept Therapeutics | 3 | $97 |
| Rhythm Pharmaceuticals, Inc. | 3 | $68 |
| Genentech USA, Inc. | 1 | $67 |
| Merck | 3 | $59 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Boston Scientific | 1 | $23 |
| Pfizer | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$352
- MINIMED 780G$129
- TOUJEO$125
- Kerendia$125
- FARXIGA$121
- TEPEZZA$119
- MOUNJARO$119
- Ozempic$116
- DEXCOM G6 TRANSMITTER$106
How this compares
$6,008 in reported general payments places this provider in the 55th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 30 | $29,641 |
| OzempicSemaglutide | 13 | $12,722 |
| JardianceEmpagliflozin | 17 | $10,551 |
| HumalogInsulin Lispro | 24 | $3,230 |
| SynthroidLevothyroxine Sodium | 46 | $2,622 |
| LantusInsulin Glargine,hum.Rec.Anlog | 20 | $1,704 |
| Atorvastatin Calcium | 50 | $349 |
| Metoprolol Succinate | 18 | $281 |
| Rosuvastatin Calcium | 16 | $206 |
| Irbesartan | 12 | $197 |
| Losartan Potassium | 22 | $188 |
| Metformin Hcl | 15 | $117 |
| Ezetimibe | 12 | $99 |
| Lisinopril | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Humalog | $119 | $32,87154 claims |
| Novo NordiskOzempic | $498 | $12,72213 claims |
| Boehringer IngelheimJardiance | $748 | $10,55117 claims |
| AbbVieSynthroid | $268 | $2,62246 claims |
| Sanofi-aventis U.S. LLCLantus | $355 | $1,70420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in San Juan
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Michelle Mangual GarciaSan Juan$743K
- Loida Gonzalez RodriguezSan Juan$246K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Oscar Ruiz BermudezSan Juan$94K
- Meliza Martinez RodriguezSan Juan$80K
- Jorge de Jesus MirandaSan Juan$30K
- Zahira Lugo LopezSan Juan$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.